Alfresa Holdings Corporation (2784.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

13.9x

EV/EBITDA

3.4x

Market Cap

JPY 423.04B

MomentumView details →

1D Return

−0.11%

YTD Return

−5.04%

RSI (14)

52.4

ValuationView details →

P/E (Fwd)

13.9x

EV/EBITDA

3.4x

Market Cap

JPY 423.04B

RSI (14)

52.4

MomentumView details →

1D Return

−0.11%

YTD Return

−5.04%

ProfitabilityView details →

Gross Margin

6.99%

Net Margin

1.10%

EBITDA Margin

1.71%

ROE (TTM)

6.77%

ROA (TTM)

2.07%

Asset Turnover

1.96x

GrowthView details →

Revenue YoY

+4.11%

EPS YoY

+0.99%

FCF YoY

—

Revenue CAGR 3Y

+4.62%

EPS CAGR 3Y

−1.33%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

1.20x

Quick Ratio

1.03x

Div Yield

2.92%

Div Rate

—

Div Growth 1Y

−10.00%

Financials snapshotView financials →

Revenue (TTM)

3.06T

Net Income (TTM)

33.64B

Op. CF (TTM)

—

Next earningsNov 5, 2026 →

Latest newsMore news →

Alfresa Holdings announced on September 1 that its subsidiary Alfresa will collaborate with two veterinary service companies to build an information-sharing platform between animal hospitals and pet owners, aiming to improve hospital operations and owner convenience.4d ago

Alfresa Holdings announced the start of sales of mesenchymal stromal cells (MSC) for regenerative medicine, manufactured by its subsidiary Cell Resources, for research and development use by pharmaceutical companies, universities, and research institutions.53d ago

Similar companies

PALTAC CORPORATION8283.T Canon Marketing Japan Inc.8060.T KANEMATSU CORPORATION8020.T SUZUKEN CO.,LTD.9987.T IWATANI CORPORATION8088.T INABA DENKISANGYO CO.,LTD.9934.T Find similar companies →

Latest newsMore news →

Alfresa Holdings announced on September 1 that its subsidiary Alfresa will collaborate with two veterinary service companies to build an information-sharing platform between animal hospitals and pet owners, aiming to improve hospital operations and owner convenience.4d ago Alfresa Holdings announced the start of sales of mesenchymal stromal cells (MSC) for regenerative medicine, manufactured by its subsidiary Cell Resources, for research and development use by pharmaceutical companies, universities, and research institutions.53d ago